Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 51

    1.

    Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.

    Rugbjerg K, Friis S, Lassen CF, Ritz B, Olsen JH.

    Int J Cancer. 2012 Jan 25. doi: 10.1002/ijc.27443. [Epub ahead of print]

    PMID:
    22278152
    [PubMed - as supplied by publisher]
    2.

    Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients.

    Poschke I, De Boniface J, Mao Y, Kiessling R.

    Int J Cancer. 2011 Dec 20. doi: 10.1002/ijc.27410. [Epub ahead of print]

    PMID:
    22190148
    [PubMed - as supplied by publisher]
    3.

    Body size and breast cancer risk: The multiethnic cohort.

    White KK, Park SY, Kolonel LN, Henderson BE, Wilkens LR.

    Int J Cancer. 2011 Nov 28. doi: 10.1002/ijc.27373. [Epub ahead of print]

    PMID:
    22120517
    [PubMed - as supplied by publisher]
    4.

    Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells.

    Devarajan E, Song YH, Krishnappa S, Alt E.

    Int J Cancer. 2011 Oct 31. doi: 10.1002/ijc.26493. [Epub ahead of print]

    PMID:
    22038895
    [PubMed - as supplied by publisher]
    5.

    High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.

    Fackenthal JD, Zhang J, Zhang B, Zheng Y, Hagos F, Burrill DR, Niu Q, Huo D, Sveen WE, Ogundiran T, Adebamowo C, Odetunde A, Falusi AG, Olopade OI.

    Int J Cancer. 2011 Oct 27. doi: 10.1002/ijc.27326. [Epub ahead of print]

    PMID:
    22034289
    [PubMed - as supplied by publisher]
    6.

    Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer.

    Reeves GK, Pirie K, Green J, Bull D, Beral V; For the Million Women Study Collaborators.

    Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26460. [Epub ahead of print]

    PMID:
    21952983
    [PubMed - as supplied by publisher]
    7.

    Hemorphin as a prognostic biomarker and potential drug for breast cancer?

    Song CZ, Wang QW, Song CC.

    Int J Cancer. 2011 Sep 22. doi: 10.1002/ijc.26450. [Epub ahead of print] No abstract available.

    PMID:
    21953447
    [PubMed - as supplied by publisher]
    8.

    High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer.

    Mathiesen RR, Fjelldal R, Liestøl K, Due EU, Geigl JB, Riethdorf S, Borgen E, Rye IH, Schneider IJ, Obenauf AC, Mauermann O, Nilsen G, Christian Lingjaerde O, Børresen-Dale AL, Pantel K, Speicher MR, Naume B, Baumbusch LO.

    Int J Cancer. 2011 Sep 20. doi: 10.1002/ijc.26444. [Epub ahead of print]

    PMID:
    21935921
    [PubMed - as supplied by publisher]
    9.

    Polymorphisms in oxidative stress-related genes and postmenopausal breast cancer risk.

    Seibold P, Hein R, Schmezer P, Hall P, Liu J, Dahmen N, Flesch-Janys D, Popanda O, Chang-Claude J.

    Int J Cancer. 2011 Sep 15;129(6):1467-76. doi: 10.1002/ijc.25761. Epub 2011 Jan 6.

    PMID:
    21792883
    [PubMed - indexed for MEDLINE]
    10.

    Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel.

    Zidan J, Sikorsky N, Basher W, Sharabi A, Friedman E, Steiner M.

    Int J Cancer. 2011 Sep 14. doi: 10.1002/ijc.26431. [Epub ahead of print]

    PMID:
    21918975
    [PubMed - as supplied by publisher]
    11.

    Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study.

    Jézéquel P, Campion L, Spyratos F, Loussouarn D, Campone M, Guérin-Charbonnel C, Joalland MP, André J, Descotes F, Grenot C, Roy P, Carlioz A, Martin PM, Chassevent A, Jourdan ML, Ricolleau G.

    Int J Cancer. 2012 Jul 15;131(2):426-37. doi: 10.1002/ijc.26397. Epub 2011 Oct 20.

    PMID:
    21898387
    [PubMed - in process]
    12.

    Surveillance of women at increased risk of breast cancer using mammography and clinical breast examination: Further evidence of benefit.

    Maurice A, Evans DG, Affen J, Greenhalgh R, Duffy SW, Howell A.

    Int J Cancer. 2012 Jul 15;131(2):417-25. doi: 10.1002/ijc.26394. Epub 2011 Oct 20.

    PMID:
    21898384
    [PubMed - in process]
    13.

    Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: Decreased tumor metastasis in a breast cancer model.

    Libreros S, Garcia-Areas R, Shibata Y, Carrio R, Torroella-Kouri M, Iragavarapu-Charyulu V.

    Int J Cancer. 2012 Jul 15;131(2):377-86. doi: 10.1002/ijc.26379. Epub 2011 Oct 20.

    PMID:
    21866546
    [PubMed - in process]
    14.

    Coffee intake and breast cancer risk in the NIH-AARP diet and health study cohort.

    Gierach GL, Freedman ND, Andaya A, Hollenbeck AR, Park Y, Schatzkin A, Brinton LA.

    Int J Cancer. 2012 Jul 15;131(2):452-60. doi: 10.1002/ijc.26372. Epub 2011 Oct 20.

    PMID:
    22020403
    [PubMed - in process]
    15.

    The risk of breast cancer in women with a BRCA1 mutation from North America and Poland.

    Lubinski J, Huzarski T, Byrski T, Lynch HT, Cybulski C, Ghadirian P, Stawicka M, Foulkes WD, Kilar E, Kim-Sing C, Neuhausen SL, Armel S, Gilchrist D, Sweet K, Gronwald J, Eisen A, Gorski B, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

    Int J Cancer. 2012 Jul 1;131(1):229-34. doi: 10.1002/ijc.26369. Epub 2011 Sep 22.

    PMID:
    21834074
    [PubMed - in process]
    16.

    Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function.

    Boniface JD, Poschke I, Mao Y, Kiessling R.

    Int J Cancer. 2012 Jul 1;131(1):129-39. doi: 10.1002/ijc.26355. Epub 2011 Aug 30.

    PMID:
    21823123
    [PubMed - in process]
    17.

    Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.

    Medeiros PJ, Al-Khazraji BK, Novielli NM, Postovit LM, Chambers AF, Jackson DN.

    Int J Cancer. 2012 Jul 15;131(2):276-86. doi: 10.1002/ijc.26350. Epub 2011 Sep 16.

    PMID:
    21823118
    [PubMed - in process]
    18.

    High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.

    Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, Abysheva SN, Suspitsin EN, Kuligina ESh, Gorodnova TV, Pfeifer W, Togo AV, Turkevich EA, Ivantsov AO, Voskresenskiy DV, Dolmatov GD, Bit-Sava EM, Matsko DE, Semiglazov VF, Fichtner I, Larionov AA, Kuznetsov SG, Antoniou AC, Imyanitov EN.

    Int J Cancer. 2012 Jun 15;130(12):2867-73. doi: 10.1002/ijc.26342. Epub 2011 Oct 20.

    PMID:
    21815139
    [PubMed - in process]
    19.

    High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells.

    Pan B, Ren H, Ma Y, Liu D, Yu B, Ji L, Pan L, Li J, Yang L, Lv X, Shen X, Chen B, Zhang Y, Willard B, He Y, Zheng L.

    Int J Cancer. 2012 Jul 1;131(1):70-82. doi: 10.1002/ijc.26341. Epub 2011 Aug 30.

    PMID:
    21805479
    [PubMed - in process]
    20.

    Mechanisms of FGFR3 actions in endocrine resistant breast cancer.

    Tomlinson DC, Knowles MA, Speirs V.

    Int J Cancer. 2012 Jun 15;130(12):2857-66. doi: 10.1002/ijc.26304. Epub 2011 Aug 29.

    PMID:
    21792889
    [PubMed - in process]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk